Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4

被引:339
|
作者
Huang, Chih-chin
Lam, Son N.
Acharya, Priyamvada
Tang, Min
Xiang, Shi-Hua
Hussan, Syed Shahzad-ul
Stanfield, Robyn L.
Robinson, James
Sodroski, Joseph
Wilson, Ian A.
Wyatt, Richard
Bewley, Carole A. [1 ]
Kwong, Peter D.
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[4] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[5] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[6] Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70112 USA
关键词
D O I
10.1126/science.1145373
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The CCR5 co-receptor binds to the HIV-1 gp120 envelope glycoprotein and facilitates HIV-1 entry into cells. Its N terminus is tyrosine-sulfated, as are many antibodies that react with the co-receptor binding site on gp120. We applied nuclear magnetic resonance and crystallographic techniques to analyze the structure of the CCR5 N terminus and that of the tyrosine-sulfated antibody 412d in complex with gp120 and CD4. The conformations of tyrosine-sulfated regions of CCR5 (alpha-helix) and 412d (extended-loop) are surprisingly different. Nonetheless, a critical sulfotyrosine on CCR5 and on 412d induces similar structural rearrangements in gp120. These results now provide a framework for understanding HIV-1 interactions with the CCR5 N terminus during viral entry and define a conserved site on gp120, whose recognition of sulfotyrosine engenders posttranslational mimicry by the immune system.
引用
收藏
页码:1930 / 1934
页数:5
相关论文
共 50 条
  • [21] A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5
    Zhao, Q
    He, YX
    Alespeiti, G
    Debnath, AK
    VIROLOGY, 2004, 326 (02) : 299 - 309
  • [22] Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry
    Nahabedian, John
    Sharma, Amit
    Kaczmarek, Maryska E.
    Wilkerson, Greg K.
    Sawyer, Sara L.
    Overbaugh, Julie
    VIROLOGY, 2017, 512 : 180 - 186
  • [23] RECOMBINANT HUMAN-ANTIBODY FRAGMENTS TO THE HIV-1 GP120 CD4 BINDING-SITE
    WATKINS, BA
    DAVIS, AE
    FIORENTINI, S
    REITZ, MS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S134 - S134
  • [24] Fluorescent CD4 probe for potential HIV-1 gp120 protein detection
    Wang, Zhongjie
    Talukder, Poulami
    Hecht, Sidney M.
    Chen, Shengxi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (06) : 1182 - 1185
  • [25] ANTIBODY AND HIV-1 GP120 RECOGNITION OF CD4 UNDERMINES THE CONCEPT OF MIMICRY BETWEEN ANTIBODIES AND RECEPTORS
    DAVIS, SJ
    SCHOCKMEL, GA
    SOMOZA, C
    BUCK, DW
    HEALEY, DG
    RIEBER, EP
    REITER, C
    WILLIAMS, AF
    NATURE, 1992, 358 (6381) : 76 - 79
  • [26] Study on molecular mechanisms of CD4 dependency and independency of HIV-1 gp120
    Liu, Meng-Ting
    Shen, Jian-Xin
    Li, Xin-Wei
    Yang, Li
    Li, Yi
    Sang, Peng
    Yang, Li-Quan
    RSC ADVANCES, 2023, 13 (09) : 6274 - 6286
  • [27] CD4-independent binding of SIV gp120 to rhesus CCR5
    Martin, KA
    Wyatt, R
    Farzan, M
    Choe, H
    Marcon, L
    Desjardins, E
    Robinson, J
    Sodroski, J
    Gerard, C
    Gerard, NP
    SCIENCE, 1997, 278 (5342) : 1470 - 1473
  • [28] Are Blockers of gp120/CD4 interaction effective inhibitors of HIV-1 lmmunopathogenesis?
    Herbeuval, JP
    Shearer, GM
    AIDS REVIEWS, 2006, 8 (01) : 3 - 8
  • [29] DISSOCIATION OF GP120 FROM HIV-1 VIRIONS INDUCED BY SOLUBLE CD4
    MOORE, JP
    MCKEATING, JA
    WEISS, RA
    SATTENTAU, QJ
    SCIENCE, 1990, 250 (4984) : 1139 - 1142
  • [30] Antibody interrogation of the CD4-bound conformation of HIV-1 gp120
    Gershoni, Jonathan
    Lewis, George
    Kaplan, Gilad
    Roitburd-Berman, Anna
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 : 58 - 58